Epiderniology has been a powerful tool in understanding the logic underlying cancer epidemiology, however, central concepts in epidemiology-the study of disease etiology-will be reviewed. ' We examine cohort and case-control studies (with special reference to studies of genetic epidemiology), we consider the impact of chance and systematic errors (confounding and bias), and we trace the process of causal reasoning. Familiarity with these concepts is essential for critical reading and understanding of the chapters on specific cancers. A glossary found at the end of the chapter provides a summary of definitions for words in italics.
'the identification of causes of infectious :..tre frequently, but not always, of infectious
ETIOLOGY

Causality
The definition of a cause should apply to all diseases, whether defined on the basis of a pafticular exposure, such as many infectious and occupational diseases, or documented by ^ constellation of clinical andf or laboratory findings-for example, malignant diseases and the elucidation of the conditions underlying epidemic outbreaks that edology. Around the middle of the twentieth century, first in the United Kingdom {Doll and Hill, 1950) and later in the United States and the rest of the world (Wynder and Graham, 1950 ; Clemmesen and Niel-*en, 1.9 57; MacMah on,'1.9 57 ), ep idemi ol o gy expanded in scope by focusing also on the etiology of chronic diseases, irrespective of the nature of the causal agents. Since then, epidemiology has developed and matured to become a rich and powerful toolbox for the study of biologic phenomena in humans. !(lith a number of fine textbooks nowadays available to students of epidemiology {for instance Miettinen, 1985; Hennekens snd Buring, 1,987;  'S7alker, 1,991,; MacMahon and Trichopoulos, L996; Rothman and Greenland, 1,998; Rothman, 2002; and several others) , this chapter is not intended to expand on methods or quantitative considerations. For the purpose of better 1, 27 tumors, connective tissue disorders, or psychoses. In terms of a particular individual, exposure to a cause of a disease implies that the individual is now more likely to develop the diseasg-although there is no certainry that this will happen. The complexiry of biological phenomena and our ignorance or limited understanding of many of the underlying processes hinder a deterministic, logically unassailable, explanation of disease causation. Hence, causation of disease can only be conceptualized in a probabilistic (stochastic) sense that involves srarisrical terms and procedures. For instance, while heavy smokers are much more likely to develop lung cancer than nonsmokers, most smokers never develop lung cancer and some nonsmokers do.
In epidemiology, there are several models of causality that have been applied to help clarify the role of various exposures in the etiology of disease. The causal pies presented by Rothman (1976) provide perhaps the most coherent approach to conceptualizing causality in a variety of epidemiologic settings (Rothman, 1, 986ir . Each of these pies describes a set of exposures that work together on the same pathway to cause disease ( Fig. 5-1) . Different exposures may occur within a short time span, or may happen decades apaft. Once every exposure in a causal pie has occurred, that is the pie is complete, disease is, in a deter*r ministic context, inevitable. Table 6 -t prw vides a summary of the attributes of th*'i causal pie model.
Causality is rarely, if ever, characterizedt
by a simple one-to-one correspondence lx'., fween a particular exposure and a specifie disease. If so, the presence of the exposure would be both necessary and sufficient fsr:;, the occurrence of the disease. By necessary we mean that the disease cannot occur without the presence of that exposure (al. r though other exposures may be required for the occurrence of the disease). By sufficient we mean a set of exposures that inevitably produce disease. There may of course bc different ways by which one could get dis': ease, and thus sufficient causes may not k,l necessary.
In cancer epidemiology, the only known, examples of exposures that are sufficient to cause disease refer to the genetic origin of some rare cancers due to dominant genei with complete penetrance. In this instance, the causal pie would require only one factot for the pie to be complete and this would h .1. The causal pie modef describes a set of exposures that work together in the same pathway to cause disease. These are hypothesized ways in which a series of exposures could interact biologically over time to cause disease. This figure provides an example of sufficient causes from cancer epidemiology. Tobacco is an established component cause in many cases of oral cancer. However, tobacco use by itself is not enough for the disease to occur; in addition, oral cancer can occur among people who have never used tobacco. In a given causal pie, the complementary exposures can occur simultaneously, or many years apart. If even one of the component causes did not occur, disease would be prevented by this pathway, although a person could develop the disease by another mechanism (a different causal pie A component cause (piece of a causal pie) can involve presence of a detrimental exposure or absence of a preventive exposure.
The amount of disease caused by a sufficient cause depends on the prevalence of all complementary component caus€s.
Component caus€s can act far apart in time
Component causes in the same pie interact biologically to cause disease Different component causes are responsible for more than 100 percent of disease cases.
Blocking the action of any component cause prevents completion of the respective sufficient cause and therefore prevents disease by that pathway.
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Certain exposures are by definition necessary (although not sufficient) for the occurrence of a particular disease. For example, chronic lead disease cannot occur in the absence of lead exposure, and a motor vehicle injury requires the involvement of a motor vehicle (MacMahon et aL,1,950; Hill, 1965; Rothman, 1.975; Susser, 1991,; MacMahon and Trichopoulos, t996) . Again, while these represent necessory causes, there are additional cofactors that must work in concert before disease is inevitable. Most human cancers can occur via several pathways, so it is hard to define any single necessary cause. Asbestos, in relation to mesothelioma (cancer of the pleura), and human papillomavirus infection, in relation to cervical squamous cell cancer, are close to being necessary. However, cases of these cancers do arise without the exposure being documentable, either because the exposure occurred but could not be identified, or because these exposures are not necessary for all cases.
For most diseases, there is no one necessary cause. Indeed there may be numerous causal pies by which disease can occur. Such an example is illustrated in Figure 5 -1, with suggested sufficient causes of oral cancer. In the first example, exposure to tobacco and alcohol over time are contributing factors (component cnuses) in the etiology of oral cancer. However, the oral cancer would not have occurred in the presence of a dental visit that could have treated precancerous lesions and might have prevented the disease. \7hile smoking is a component cause in many causal pies for oral cancer, people can get oral cancer without smoking, as shown by the second causal pie in this figure.
Interventional Epidemiology
How do we design a scientific study to evaluate whether a particular exposure (for example, asbestos) is a cause of a specific disease (for example, lung cancer)? To understand the most appropriate design in practice, it is useful to begin by describing the ideal scientific study. Imagine for a moment that we have access to a time machine.
In an imaginary study, we follow a group of individuals from birth to death, where everyone is exposed to asbestos, and we observe whether they develop lung cancer. We then send everyone back in a time machine, to live the exact same lives they lived, except that we completely remove asbestos from the environment so that no one is exposed. I7e then compare whether there are changes in the frequency of occurrence of lung cancer before and after use of the time machine. Since the same people live identical lives but for the presence/absence of asbestos, any difference in the frequency may be attributed to alterations in the exposure to asbestos, which leads to the definition of cause.
How then can we develop the time machine analogy into a realistic epidemiologic approach? \7e could study two groups of people who are comparable on every characteristic, except that one group had exposure and one did not. The randomized controlled trial closely approximates this goal. By randomly allocating who receives an exposure, for example treatment, and who does not, the exposure occurs only because the investigator has assigned it. For example, an investigator randomly assigns one group of people to receive vitamin E supplements (exposed), while the other group receives a placebo (unexposed). Study participants are then followed forward in time to see whether they develop cancer. Ifhether someone receives vitamin E then does not depend on whether or not the subject, for example, smokes, drinks, eats a high-fat diet, or has a certain genetic susceptibiliry.
In this wly, the randomization in a trial makes the two (or more) groups, those exposed and those unexposed, comparable on other study factors that might cause the disease. Hence, the unexposed group is a proxy of what would have happened to the exposed group if they had been unexposedthat is if we could have sent them back in the time machine. Comparability is essential in order to ascribe any changes in the frequency of disease to alterations in the exposure.
\fhile some researchers describe the randomized controlled trial as the goldstandard of scientific studies, this design is impractical in the majority of epidemiologic situations. For one thing, most exposures we study are detrimental. If we want to study the impact of asbestos on lung cancer, we cannot ethically randomize people to live in a house with asbestos. But even for exposures that are not necessarily. detrimental, randomization may be difficult or impractical. For instance, it is very difficult and expensive to randomize alarge group to eat a low-fat versus a normal diet, and have everyone comply with this allocation over the course of many years. Most trials are .
thus only conducted for no more than a few years, an unrealistically short period to test the effect of most exposures because of the long latency between exposure and diagnosis of cancer. Furthermore, in many randomized trials, subjects become noncompliant over time-that is people allocated to the intervention arm stop taking the intervention, and those in the original placebo or usual care arm may adopt the intervention (a phenomenon called cross-over). This diminishes the contrast between the original randomized groups, reducing the power to detect a difference in disease rates between the groups. Because of the limitations of the randomized controlled trial, the observational cohort and case-control designs are extensively utilized in epidemiology. As will be discussed later in the chapter, attention to both the design and analysis of these studies may allow us to approximate the standards of comparability, necessary to validly evaluate the effect of an exposure on the frequency of a disease.
Observational Epidemiology
The essence of observational epidemiology is the noninteruentional investigation of disease causation in human population groups. The argument is that only by studying humans is it possible to draw confident conclusions about normal or pathological processes concerning humans (MacMahon, 7979; MacMahon and Trichopoulos, 1, 996) . In vitro studies, such as those involving cell cultures, and studies in laboratory animals are valuable. They are indeed indispensable when toxic exposures or invasive procedures like repeated biopsies are needed for the study of physiologic or pathologic processes, such as carcinogenesis. However, in vitro systems are frequently artificial, and there are physiological and metabolic differences between humans and laboratory animals that hinder interspecies analogies. These analogies are further complicated by the unavoidably limited number of animals used in laboratory studies and the relatively CON( short life span of thes which impose the adn doses of suspected agen ate a sufficient number sequently, questionable olations to humans hav Even when experime randomized controlled r ethical, they are, with practical because most ( their latent period, that exposure to a cause and clinical disease, is long, essary to enroll unreal bers of compliant volun period (Hennekens a MacMahon, 1979; M chopoulos, 1996) .
Observational, that r studies represent the ma epidemiology. Such stt ment causal relations o ciations berween partic cancer or other disease sation on the basis of when the association biologically credibleeancer, or hepatitis B ' cer, are striking exampl difficult when the associ eompelling but the ep ence weak-for exampl level ionizing radiatior passive smoking and I interpretation also be, when the epidemiologic convincing but the bic uncertain, as it is with gnd colorectal cancer ol {ancer. I7hen an epider ir weak, is derived fron tionable quality, and fl Ygcuum, inferring caus: STUDY D Descriptive Studies It is possible to distin; epidemiological studies *nnlytic. In descriptive s BACKGROUND rhort life span of these animals, both of of occurrence of a disease (incidence)-which impose the administration of high or of death from a disease (mortality)-is ' doses of suspected agents in order to generestimated in a population, by routinely *te a sufficient number of outcomes. Conavailable time, place, andf or group charac-'ffquently, questionable quantitative extrapteristics. Descriptive studies are essentially olations to humans have to be undertaken. exploratory and hypothesis generating. Even when experimental studies, such as For instance, descriptive studies that docursndomized controlled trials, in humans are mented the increasing trend of lung canethical, they are, with few exceptions, imcer incidence among men, but not among practical because most diseases are rare and women, in the early part of the twentieth their latent period, that is, the time berween century pointed to tobacco smoking as a cxposure to a cause and the appearance of a likely cause of this disease. In contrast, the clinical disease, is long. This makes it necobjective of analytic studies is to document rssary to enroll unrealistically large numcausation from the pattern of association in bers of compliant volunteers for a very long individuals between one or more exposures period (Hennekens and Buring, t987;  on the one hand, and a particular disease on MacMahon, 1979; MacMahon and Trithe other. chopoulos, L996).
Observational, that is nonexperimental, EcologicStudies studies represent the mainstream of modern Ecologic studies in epidemiology occupy an epidemiology. Such studies seek to docuintermediate position berween descriptive ment causal relations on the basis of assoand analytic investigations, in that they ciations between particular exposures and share many characteristics with descriptive cancer or other diseases. Inference of caustudies, but serve etiologic objectives. In sation on the basis of association is easy ecologic studies, the exposure and the diswheir the association is both strong and ease under investigation are ascertained not biologically credible-smoking and lung for individuals but for groups or even whole cancer, or hepatitis B virus and liver canpopulations (Morgenstern, 1, 952) . Thus cer, are striking examples. It becomes more the prevalence of hepatitis B virus (HBV) difficult when the association is biologically in several populations could be correlated compelling but the epidemiologic experiwith the incidence of liver cancer in these ence weak-for example, in studies of lowpopulations, even though no information level ionizing radiation and leukemia or could be obtained as to whether any parpassive smoking and lung cancer. Causal ticular individual in these populations was interpretation also becomes problematic or was not an HBV carrier and has or has when the epidemiologic association is fairly not developed liver cancer. Associations convincing but the biological rationale is from ecologic studies are viewed with skepuncertain, as it is with respect to red meat ticism, because these studies are susceptible and colorectal cancer or alcohol and breast to unidentifiable and intractable confoundcancer. Vhen an epidemiologic association ing as well as to several other forms of bias is weak, is derived from a study with ques- ( Rothman and Greenland, 1998) . The objective of analytic epidemiologic studies is to ascertain whether a particular exposure, such as a physical, chemical, or biological agent, and a specific cancer or other disease are unrelated (independent) or associated. An association does not necessarily indicate causation. Chance, bias, and confounding (see following) can also generate associations, and they frequently do. Causation is unlikely when there is no association observed. Even if a causal relation does exist, however, it may sometimes be difficult to document it, particularly when the association is weak, the study has limited statisticalpower, or the exposure is seriously misclassified.
Person-time and Study Base
The concepts of person-time and study base are fundamental to the design and analysis of epidemiologic studies. As the name implies, there are two key components in our description of the person-time, namely the number of people and the time they are followed. To illustrate this, we could ask how many brain cancer cases we would expect if we followed one million people exposed to x-rays f.or zero seconds. Conversely, how many cases would we expect if we followed zero people for one million years? The answer in both instances is, of course, zero. Hence, neither people nor time alone provides adequate information about the disease experience of a population, and thus both should be taken into account. Person-time is the sum of all the time contributed in a study by subjects at risk of a disease. Theoretically, an ambitious investigator might wish to include the entire world population in an epidemiologic study during many decades. Needless to say, such a study would provide marvelous opportunities to evaluate many different exposures in relation to many diseases. Millions of personyears would be generated even within a few weeks.In real life, however, any investigator has to restrict the person-time from which information is harvested. This specified person-time is called the study base. Defining the person-time to be included in the study base may include geographic restrictions, defined time periods, and certain age limits. Personal characteristics such as gender, ethnicity, and occupation may further specify the study base. For example, the study base may be comprised of all British doctors who answered a questionnaire in 1,951. (Doll and Hill, 1.9561 , or by all Swedish women who were aged 50 to 74 between"l. 994 and 1995 (\ilTeiderpass et al,'1,999) ,and who generated person-time until they died or until the follow-up was completed.
Thus, the study base is simply the persontime of a population of individuals at risk of a disease under study. Defining the study base is a crucial step in the design and conduct of an epidemiologic study. There are three central considerations. One is to accommodate realistic goals with regards to feasibility and resources, as certainly no investigator is independent of time and money. A second goal is to make the study efficient. For example, it would make little sense to study the association between smoking and cancer in a population where very few are smokers. Likewise, a study of diet and prostate cancer would be inefficient among men younger than 40, since virtually no cases arise among such young people. The final challenge is to identify a study base that allows valid inferences concerning associations between exposure(s) and a particular disease-that is, a study base that does not impose intractable confounding or raise insurmountable obstacles of other biases. Person-time is the source of any event we want to investigate, for example the occurrence of cancer. To help set a foundation for better understandingperson-time in a study base, we will use the example of x-rays and risk of brain cancer ( Fig. 6-2 ). In this population, five people have been exposed to xrays, and another five have not been exposed and remain unexposed during the study period. \7hile in real life the study populations are much larger, we use this elementary example to illustrate the principles.
Among the people exposed to x-rays, persons 3 and 5 were followed from the rime they were exposed to x-rays till the end of the study period-a total of 5 years each. Persons l, 2, and 4, however, developed lrrain cancer at the end of years 1.,4, and 2, respectively. Once these individuals develop brain cancer, they are no longer at risk of the disease, and thus no longer contribute information to the study base. The persontime among those exposed to x-rays is estimated by summing up the person-time of all the individuals while at risk for the disease, that is: Later on when we discuss analysis of epidemiologic studies, we will see how the l;igure 5.2. Experience of a theoretical study population over time. Five individuals who were cxposed to x-rays and five individuals who are unexposed are followed over time to see if they develop brain cancer. Among those exposed to x-rays, persons 3 and 5 are followed for the duration of the study period, which in this case was five years. Person 1 develops brain cilncer after L year, person 2 develops brain cancer after 4 years, while person 4 develops c:rncer after 2 years. Persons 1,2 and 4 stop contributing person-time after they develop brain eilncer, since they are no longer at risk for the disease. The total person-time in the exposed group is 17.0 person-years.Similarly, w€ can look at the population of people unexposed to x-rays over time. Of the five people who are unexposed, only one develops brain cancer during thc study period (person 9). The remaining people are followed completely for five years.The rxperience of these ten individuals over time, that is the person-time that the subjects conrihuted, is the study-base. person-time data will help us to compare disease incidence between exposed and unexposed people.
Cohort studies
The word cohort derives from the similar Latin word, which identified one of the ten divisions in a Roman legion. In epidemiology, cohorts are groups of individuals, which can be followed over time. In cohort studies, individuals are classified according to their exposure and are observed for ascertainment of the frequency of disease occurrence or death in the various exposuredefined categories . In each category the frequency of occurrence is calculated either as risk or as incidence rate. Risk describes the proportion of those who developed the disease under study among all individuals in this category. Rate describes the number of those who developed the disease divided by the person-time during which the individuals in this category have been under observation. Cohort studies have the following defining characteristics. Cohort studies are exposure-based. The groups to be studied are selected on the basis of exposure. In special exposure cohorts, the groups are chosen on the basis of. a particular exposure. In general population cohorts, groups offering logistical advantages for follow-up are initially chosen and the individuals are classified according to their exposure status. Special exposure cohorts may be necessary when rare exposures need to be studied, such as those encountered in the occupational setting. For example, to study efficiently the effect of vinyl chloride on liver angiosarcoma, or aromatic amines on bladder cancer, epidemiologic studies have been conducted in cohorts of workers in the plastic and dyestuff manufacturing industries, respectively. The general population cohort is appropriate when the exposure under consideration is fairly common. Classical examples of general population cohorts, in which the profession facilitated accessibility of cohort members rather than being a study factor, include the British Doctors Study and the Nurses Health Studv. The British Doctors cohort, established in "1.951, consisted of more than 30 000 doctors from Great Britain. In this landmark study, Doll and colleagues prospectively followed the cohort and collected updated information on multiple exposures, particularly smoking, over several decades. Indeed, prospective data from the British doctors were among the first to demonstrate convincingly the role of tobacco in the etiology of lung cancer (Doll and Hill, 1, 9561 . More than four decades later, data from the British Doctors have continued to provide insight into the etiology of cancer (Doll et al, 2005) .
Another notable cohort is the Nurses Health Study, which began in 1976 with over 120 000 US registered nurses. This cohort was assembled initially to evaluate prospectively the effect of oral contraceptives on the risk of breast cancer (Hennekens et al, 1984) . Subsequently, diet and many other exposures have been studied in relation to the risk of cancer as well as other chronic condition s (Zhang et al, 2005 ) . Information on these diverse exposures has been collected biennially through questionnaires. Moreover, blood samples have allowed researchers to explore biomarkers and genetic factors. For example, prospective data from the Nurses Health Study has provided insight into the role of both exogenous and endogenous estrogens in breast cancer etiology. A particular characteristic of these types of cohorts is that the individuals can be followed almost completely over time, due to their membership in groups with a high interest in health studies and registration requirements that facilitate initial contact and long-term follow-up.
Cohort studies are patently or conceptually longitudinal.The study groups are observed over a period of time to determine the frequency of disease occurrence among them. The distinction beween retrospective and prospective cohort studies depends on whether the cases of disease occurred in the cohon at the time the study began. [n a retrospective cohort study, exposures and health outcomes occurred before the investigation started. These are typically assembled from pre-existing records of a linlted to recorded he ',''j "$ation of the worker Figure 6 .3A. A cohort study comprises individuals who are either exposed or unexposed to the factor(s) of interest. When these people are followed over time, they generate person time.
Newly diagnosed cases of a particular disease, that occur while person-time is accumulated are recorded. The exposure status of a person can change. A person could be smoking high tar cigarettes for five years, then switch to light cigarettes for fifteen years, and then quit. Con-*cquently, each person can contribute to person-time in different exposure groups. A case is eonsidered exposed, if the disease occurred when the person who developed the disease was accumulating exposed person-time. A case is non-exposed if it occurred while the person was accumulating non-exposed person time. The example assumes, for simplicity, zero latency. The total amount of exposed and non-exposed person time and the number of exposed lnd non-exposed cases can be calculated. After that, one can determine whether more cases occurred in the exposed or non-exposed group per unit of person-time, that is, one can calculate the incidence rate ratio. This ratio will indicate whether there is a relationship between the exposure and the disease of interest.
population over time-for example, the emship in the cohort is determined. In a closed ployment histories of a factory can be cohort, it is determined by a membershiplinked to recorded health-outcome infordefining event that occurs at a point in time. mation of the workers. In a prospective For example, people who were living in cohort study, the relevant causes may or Hiroshima and Nagasaki when the atomic may not have acted and the cases of disease bombs were dropped in 1945 are part of certainly have not yet occurred. Hence, a cohort whose membership began on the following identification of the study cohort, date of the bombing. These subjects remain the investigator must wait for the disease to in the cohort until they die. rppear among cohort members.
Open I Non-exposed person-time (Ps) :
used, for example, in cancer epidemiology studies based on registry data (Hansson et al, 1996) . A person could be a member of the cohort, for example, only as long as he or she was a resident of Sweden and was not diagnosed with the cancer under srudy. If the person emigrated from Sweden to another country, he or she stopped contributing person-time to the cohort at that time.
Similarly, if someone born outside of Sweden immigrates there later in life, he or she would begin contributing person-time to the cohort at that time. In studies based on open cohorts it is not possible to directly measure risk, otherwise referred to as cumulatiue incidence. Analyses are based on person-time using incidence rate measures.
As an example, assume that in a closed cohort among 5000 nonsmoking men followed for an average period of L0 years (Po:50 000 person-years), xo:25 were diagnosed with lung cancer, and among 10 000 smoking men followed for an average period of 8 years (Pr:80 000 person-years), Xr :500 were diagnosed with lung cancer. In this example the incidence rate among nonexposed would then be 50 per 10' person-years and among exposed 750 per 1.05 person-years. The reilatiue risk (incidence rate ratio) would b. ffiffi, ot L5. The conclusion is that there is'a 1S-fold increase in lung cancer occurrence from smoking.
Case-control Studies
In case-control studies, patients diagnosed with the disease under consideration form the case series. As in cohort studies, their exposure to the f.actor under investigation is ascertained, for example, through questionnaires, interviews, examination of records, undertaking of laboratory tests in biological samples, and other means . Using the same methods, the pattern of exposure to the study factor(s) is then estimated in the population, or more strictly in the person-time from which the case series arose. This is done among control subjects selected as a sample of the study base from which the cases arose. If only rwo categories of exposure are relevant (exposed and unexposed), the relative risk can be estimated by dividing the odds of exposure among cases with the corresponding odds among the controls, the odds ratio. Thus, if among 200 male patients diagnosed with lung cancer (cases), a:'1.50 were smokers and b:59 nonsmokers, whereas among 300 men similar in age to the cases but without lung cancer (controls), c-50 were smokers and d--250 were nonsmokers. the odds ratio would be #-#-ffi or 15. This measure is a good approximation to the relative risk (or risk ratio, or rate ratio). Hence, similar to the cohort study, these data from a casecontrol study show a 1S-fold excess of lung cancer among smokers.
There are some features of case-control studies that make this design susceptible to bias (see following). A well-designed casecontrol study, however, is a valid and costefficient approach to the study of the etiology of cancer and other conditions. Nested case-control studies Some case{ontrol designs are methodologically superior to others. The best example is the nested case{ontrol design. The definition of this study design is still somewhat ambiguous (\ilfalker, 1991,; Rothman and Greenland, 1998) . A definite requirement, however, is that controls are chosen from the clearly defined person-time from which all cases have arisen. In other words, if one of the controls had developed the disease under study, he or she would have definitely been included among the cases. Defining the underlying person-time from which a series of cases-for example, lung cancer cases presenting at a referral hospital-arose can be difficult. Sampling controls from a cohort different from the one that gave rise to the cases often results in selection bias.
According to a more strict definition, the term nested case-control study is used only when the underlying cohort and the corresponding person-time have been previously enumerated and the exposure information was collected prior to the diagnosis. In other words, the controls are selected from exactly the same person-time that gave rise to The case<ontrol study is a more efficient design. Instead of enumerating the total amount of exposed and unexposed person time that makes up the study person-time, the ratio of exposed to unexposed person-time is estimated. This is achieved by randomly selecting people {controls) without rhe disease of interest from the underlying study person-time and determining their exposure status. If a sufficient number of controls are selected, without regard for their exposure status, then the exposure distribution in the controls will estimate that in the total study person-time. The exposure distribution among the controls is then compared to that among the cases of the disease of interest that have arisen in the study person-time. An estimate can then be made of the odds of exposure among the cases compared to that among controls, or the odds ratio, which is an unbiased estimator of the incidence rate ratio and so indicates whether there is an association between the disease and the exposure of interest.
the cases, the study base. Unlike the tradilogic samples such as blood or blood prodtional case{ontrol design, which is liable ucts, tissue, urine, or nails. to bias due to selective participation and One such example is a study of selenium differences in recall, this nested design prestatus and breast cancer risk in the Nurses' $erves the validiry of a prospective cohort Health Study (Hunter et al, 1990 ). On study. Case<ontrol studies nested in an exthe basis of prior evidence that selenium isting cohort are being used increasingly for intake may influence breast cancer risk and cost efficiency when analysis of all cohort since selenium levels in toenails are a relimembers requires substantial resources. able source of selenium exposure over sevNested case-control studies have been eral months, the participating women were frequently used in occupational epidemiasked to provide toenail clippings in 1982. ology (Rothman and Greenland, 1998) . The After 4 years of follow-up, there werc 434 occupational cohort can often be readily cases of breast cancer. It would have been defined whereas abstraction of detailed exvery expensive and inefficient to get expoposure information from existing records sure information for all the 62 000 nurses requires substantial work. Hence, it is more who had returned toenail samples at the efficient to investigate only the cases of instart of follow-up. Hence, 434 controls terest and a sample from the cohort that without breast cancer were sampled from is the controls. Nowadays, nested casethe cohort. Using this design meant that control studies are used routinely when exonly 858 rather than 62 000 samples had to posure information is derived, often through be sent to the laboratory for selenium anaexpensive laboratory procedures, from biolyses (Hunter et al, t990) .
tr tt I Non-exposed person-time (Po) :
Matching in case-control studies generally rare, presumably because of natural selection pressure. Genetic association studies can be of either cohort or, mo[e frequently, casecontrol design. They are frequently undertaken in the general population, rather than in families, and are conceptually similar to traditional epidemiological investigations. The difference is, however, that instead of focusing on environmental factors, like smoking or diet, genetic association studies evaluate as "exposures" specific alleles (rather than loci) of genetic polymorphisms, usually single nucleotide polymorphisms (SNPs). The specific alleles may be etiologically related to cancer or, much more frequently, very closely linked to the truly etiological allele which may not be known. The actually investigated allele and the true etiological allele are said to be in linkage disequilibrium-that is, they are so closely linked that they tend to be inherited together. Two loci in linkage disequilibrium are obviously linked, but two linked loci may not be in linkage disequilibrium if they are sufficiendy apart in the chromosome to be separated, sooner or later, by the frequent cross-over process in the meiosis phenomenon during the generation of gametes. In other words, linkage covers longer genetic regions than linkage disequilibrium (Cordell and Clayton, 2005; Teare and Barrett, 2005) . The specific allele may be chosen to study because the corresponding locus is thought to be involved in the etiology of the cancer under investigation (eg, a candidate gene). Many SNPs over large parts of the genome, or even over the whole genome, may also be evaluated, with little or no prior evidence that most of them are etiologically relevant or are in linkage disequilibrium with etiologically relevant genes. In the latter situation, most statistically significant findings are likely to be false positive and special procedures are recommended to delineate which ones among the apparent associations are probably genuine (\Uflacholder et al, 2004) . Genetic association studies have not been very successful to date in identifying genes or polymorphisms involved in cancer etiology, possibly be- 
' ,l-' l{X} people have tossed ,:.. r'oin five times each, it s BACKGROUND Occasionally, case-control studies are matched. This means that controls are chosen so as to match particular cases with respect to gender, age, race, or any other factor that is likely related to the disease under investigation but not intended to be analyzedin the particular study. Matching is not strictly necessary, nor does it increase the validity of results. But it improves statistical efficiency and, thus, the ability to substantiate a true association (Rothman and Greenland, L998) . \(ihat is necessary, however, is that, whenever matching has been used in the enrollment of cases and controls, the statistical analysis should accommodate the matching process. This can be done through either a matched analysis (for example, conditional modeling) or unmatched analysis with explicit control for the matching factors (proper application of unconditional modeling).
Studies of the Genetic Epidemiology of Cancer
Genetic epidemiology of cancer is considered in more detail in a distinct chapter (Chapter 4). Here, we refer briefly to such studies, to provide an integrated picture of epidemiologic designs available for the study of cancer etiology. Two main types of epidemiologic studies are used for the identification of genes predisposing to cancer: genetic linkage studies and genetic association studies. Genetic linkage studies are generally undertaken in families with a high cancer burden and rely on the principle that two genetic loci, or a cancer and a particular locus, are linked when they are transmitted together from parent to offspring more often than expected by chance. Linkage extends over large regions of the genome and refers to a locus, rather than specific alleles in that locus, which can vary from study to study and from family to family (Teare and Barrett, 2005 It must be real:r,ed that stochastic (probabilistic), in contrast to deterministic, processes always have built-in uncertainty. In their research, all investigators want to reduce chance-related uncertainty as much as possible in order to allow more reliable conclusions. This can be achieved mainly by enrolling progressively larger numbers of individuals in a study. The remaining uncertainty can always be assessed by utilizing statistical procedures that generate a number of summary statistics, including the p-ualue.
The true meaning of the p-ualue, however, is poorly understood and the concept itself is widely misused. Surprisingly, this misunderstanding and misuse is quite common even in scientific research. Traditionally, p-ualues arc expressed as numerical fractions of 1. For example, a p-ualue of 0.1. for a particular positive association (or difference) indicates that there is a 10i" chance that such an association or a more extreme one (or a symmetrically opposite one-that is an inverse association) would appear by chance, even if there were in reality no association at all.
In essence , the p-ualue is interpretable as such when only one comparison or one test is performed.
'!7hen multiple comparisons or multiple tests are carried out the set of the respectiye p-ualues loses its collective interpretability. Various procedures for adjusting p-ualues according to the number of comparisons undertaken or tests performed have been proposed (I7acholder et al, 2004) . A p-ualue of 0.05 or smaller is uaditionally-and indeed arbitrarilytreated in medical research as evidence that an observed association may not have arisen by chance. For example, the proportion of long-term smokers is found to be larger among lung cancer patients than among individuals without the disease and the p-ualue for this difference is, S8I, 0.05. This implies that the probability of finding a difference of this magnirude or larger (in absolute terms) is 5% if smoking were CONCEPTS IN CANCER EPIDEMIOLOGY AND ETIOLOGY association could therefore deserve terms, the role of errors should be :The P-value 'Our daily lives are full of highly unlikely wents and coincidences. At the extremes, thousands of people have become wealthy .from lotteries; many more have died in :ltrange accidents, even though the probabil--lties for the respective events are extremely ,imall+ay one in 100 000 or smaller. The lesson is simple: Highly unlikely events lrapp.n by chance all the time. Chance does ..not operate differently in scientific research ,tttd everyday life. In science, however, -proper quantification and judgment, relying i on sound substantive knowledge, are nec-'sBrI before considering chance as an unlikely explanation for a phenomenon. . Let us take, as an example, tossing a f.atr {unbiased) coin that has a 50% or 0.5 probability of turning up heads and an identical probability of turning up tails. ,:Tossing the coin three times and getting three heads in a row is somewhat unusual but it can hardly be taken as an indication that the coin is systematically influenced '{biased) toward tails. The p-ualue tn this instance is 0.25 and is calculated by multiplying 0.5 x 0.5 x 0.5 -0.'1.25, and then ,doubling 0."1.25, because the symmetrically opposite outcome, three tails in a row, is as .: txtreme as three heads in a row. Getting five heads or tails in a row generates some ruspicion 1p:[r/z]5 x2-0.06251. But if ,100 people have tossed a fair (unbiased) coin five times each, it should be expected t40 unrelated to lung cancer. In this situation, chance is considered unlikely to explain the association. However, small p-ualues, including values considerably smaller than 0.05, do not guarantee that an association (or difference) is genuine-let alone causal.
Even when the p-ualue is very small and was generated from a carefully conducted study, it could still be dismissed when the relevant result makes no sense (Miettinen, 1985) . Hence, a statistically significant association, linked by convention to a p-ualue of 0.05 or less, does not necessarily imply causation. Systematic errors, generated by confounding or bias (see following), cannot always be confidently discounted in observational epidemiology. Moreover, as indicated at the end of this chapter, the existence of a genuine association that can be confidently attributed to causation does not necessarily imply that someone who developed the disease following the exposure did so because of that exposure.
A common misconception (Miettinen, 1985) is that if a p-ualue (for example, 2:0.03) has been properly derived, then its complement (0.97 in our example) can be interpreted as the likelihood that the respective association is indeed causal. This misconception is rarely stated explicitly in the scientific literature, but it underlies the conclusions of many epidemiologic reports that are not securely anchored in methodological principles and biomedical substance.
Lastly, it must be recognized that the pualue itself does not convey any information about the strength of the respective association. A weak association may be statistically highly significant (very small p) when the study is large, and a strong association may be statistically nonsignificant (larye p) when the study is small. Hence, all p-ualues are inherently dependent on the study size, because statistical power-the abiliry to detect an association (or a difference) when it exists-increases when a study is larger (Rothman and Greenland, 1998) .
Confidence Intervals
In order to integrate information about the strength of an association (as reflected in the relative risk-effect measure, described later on) and its statistical significance, the concept of confidence interual has been developed. Most common are 95"h confidence intervals. With a 95o/" confidence interval, one can be 95t/" confideht that the interval covers the true measure of association (for example the relative risk). But in 5 times out of 100, the true measure is not included. The confidence interval is closely linked to the p-ualue. The width of the confidence interval is determined primarily by the desired level of confidence and the sample size. Hence, the interval is wider if it includes the true value with 95% confidence than with, for example, 80% confidence. Likewise, smaller studies create wider confidence intervals-that is, greater uncertainty about the true value-than larger studies.
SYSTEMATIC ERRORS The Experimental Study
The chance-related issues apply to all types of studies, observational as well as experi mental. As discussed earlier, experimental studies undertaken under optimal conditions are methodologically superior to observational studies. With randomization of exposure, complete follow-up of srudy subjects, and double-blind assessment of outcome, they are not as liable to the pitfalls of typical observational studies-that is confounding and bias (Miettinen, 1985; Hennekens and Buring, t987; MacMahon and Trichopoulos, 1996; Rothman and Greenland, 1998; Rothman,2002) . Proper evaluation of the association between a particular exposure and a specific disease presupposes that every other factor that could influence disease occurrence is either constant among subjects studied or distributed equally befween exposed and unexposed subjects.
In other words, an experimental study uses random allocation of study subjects into those who will be exposed and those who will not. Thus, the two or more groups will tend to be similar in distribution to known as well as unknown factors that may influence the results. In some studies, Rothman and Greeny 2002) . Proper evalurn benareen a particular fic disease presupposes or that could influence either constant among iistributed equally bernexposed subjects. m experimental study rion of study subjects be exposed and those :he two or more groups ilar in distribution to unknown factors that :sults. In some studies, blinding of researchers and study subjects tluough the use of appropriate procedures rnd devices (for example, indistinguishable inert pills, the so-called placebos) may further assure that every factor that can affect disease occurrence, other than the exposure [nder study, is kept at about the same level htween the exposed and unexposed groups.
Experimentai studies aim to fulfill the Latin dictum ceteris pariba (other things hing equal). However, in humans, the op-. timal conditions that completely eliminate confounding and bias are difficult to create cven in randomized controlled trials. Moreover, as already indicated, there is no way to fully control the inherently unpredictable role of chance, except by the use of very large numbers of study subjects-an unrerlistic objective in many studies. . The randomized controlled trial, with its methodological advantages, dominates experimental research in laboratory animals.
[n humans, however, the undertaking of cxperiments faces serious obstacles, the most important of which are ethical. It is obviously not acceptable to expose humans intentionally to a potentially carcinogenic ggent in order to ascertain cancer causation. For this reason, most randomized controlled trials in humans have been perbrmed to evaluate treatment effectiveness end occasionally to determine the preventive potential of vaccines, vitamins, or other supplements. In most instances, research on disease etiology has to rely either on animal models-with inherently dubious as-141 sumptions about interspecies similarities and exposure dose extrapolations-or on epidemiologic studies with an observational design.
Epidemiologic studies have indeed generated most of what is currently known about the etiolory of human diseases in general, and cancer in particular. At the same time, however, epidemiologic studies have also generated conflicting results, unwarranted concern about everyday exposures, and considerable confusion over the rational ranking of public health priorities (Taubes, 1, 995) . The problem arises because epidemiologic studies must confront not only the vagaries of chance but also the problems of systematic errors that undermine their validitv.
Confounding
Confounding is the systematic error generated when another factor that causes the disease under study, or is otherwise related to it, is also related to the exposure under investigation (Fig. 6-aA) . Thus, if one wishes to examine whether hepatitis C virus (HCV) causes liver cancer, hepatitis B virus (HBV) would be a likely confounder. Confounding arises because HBV causes liver cancer and carriers of HBV are more likely to also be carriers of HCV (because these rwo viruses are largely transmiffed by the same routes). Hence, if the confounding influence of HBV is not accounted for in the design (by limiting the study to HBVnegative subjects) or in analyses of the data, CONCEPTS IN CANCER EPIDEMIOLOGY AND ETIOLOGY Figure 6 .4A. Infection with hepatitis C virus (HCV), a cause of liver cancer, is (positively) confounded by hepatitis.B virus (HBV) infection, another cause of liver cancer. If this confounding is disregarded, the strength of the association between HCV and liver cancer will be overestimated.
BACKGROUND CONC then the strength of the association between HBC and liver cancer would be overes_ timated (Fig. 5-aA) .
A more trivial example is the strong as_ sociation between carrying matches l, " cigar_ette lighter and developing lung can_ cer. Obviously, neither matches nor lilhters c.ause lung cancer and their associati,on to the disease is due entirely to confounding by cigarette smoking. The confoundin g f^J tor, cigarette smoking, is the true cause of lung cancer and the dependence of cigarette lighting on match., oriighters generates the confounded, entirelv sfurious association of the lafter rwo factois with the disease (Fie. 5-aB).
There are several ways to deal with confounding: some simple, others more complicated. They all assume that two con_ ditions are satisfied: (1) rhat all the con_ founders have been identified or at least suspected, and (2) that the identified or suspected confounders can be adequately conceptualized and accurately measured. $7hen.the study is fairly large, it is always possible to evaluate all zuspected confound_ ers in the analysis. However, the abilirv to-conceptualize and accurately -."rrr. all of them is frequently beyona in. conrrol of any investigator. The result is what has been rermed residual confounding, that is, confounding left unaccounted for (Mac_ Mahon and Trichopoulos, 1996; Rothman and Greenland, 1999) .
Bias
.Compounding the problems of epidemiologic studies is that the data are almost never of optimal quality. Data collection relies on the recollection of exposures and their accurate reporting by study partici_ pants, laboratory procedures, or existing records. These sources are rarely p.rf..tl For example, studies on diet rely on indi_ viduals' imperfect recall on how irequently they eat specific foods, or on serum markers of nutrients that are far from perfect indi_ cators of long-term consumption. Such misclassificarion, or informatiin bias, can influence the relative risk in any direction and, thus, entails exaggeration, underesti_ mation, or even reversal of the true associ_ ations. In case-control studies, the ascertain_ ment of exposure occurs after the occur_ rence of disease. Therefore, this study de_ sign is parricularly subject to information bias. In particular, cases may be likely to remember their exposures differently ihan controls-a form of information bias called recall bias. For example, a reasonable con_ cern is that cases, or their relatives, are in_ clined to ruminate about the disease and identify a particular exposure as the caus_ ative agent, either for conscious or subcon_ scious reasons. Cases may also try harder than controls to recall relatives with the disease of interest, leading to a biased esti_ A well thought-out protocol, standardired procedures, and built-in quality control measures can reduce bias and allow rome quantification of its potential impact. However, complete assurance that bias has treen eliminated can never be achieved. In rddition, the reliance of case{ontrol studi*s on a control series that simultaneously has to meet criteria of compliance, comparebility to the case series, statistical effieiency, and general practicality makes them *usceptible to selection bias of unpredicteble direction and magnitude. Such biases arise when eligible controls are not reprefcntative of the population, or more strictly the person-time, that gave rise to the cases (Vacholder et al, 1,992a; I(acholder et al, 1992b;  'sfacholder et al, 1.992c). Assume as in the same previous example that controls refuse to participate more often if they are smokers than if they are nonsmokers. We would then underestimate *moking in the control group and thereby overestimate both the difference between eases and controls and the excess risk. Hospital controls, neighborhood controls, and Gontrols enrolled through searches of telephone lists have their own problems, and these have been extensively discussed (MacMahon and Trichopoulos, 1995) .
In contrast to selection and information biases, issues of chance and confounding are equally relevant to cohort and case-control investigations (Hennekens and Buring, 1987 ; MacMahon and Trichopoulos, 1,996; Rothman and Greenland, 19981 .
ANALYSIS OF EPIDEMIOLOGIC STUDIES Effect Measures
The underlying goal of epidemiology is to determine the rnagnitude of change in dis-:ease frequency caused by an exposure. How , do we accomplish this? \fle could measure ,the cumulative incidence or incidence rate gmong those exposed to a factor. For example, we could observe that the incidence 143 rate of breast cancer in a population of alcoholic women is 50/10 000 person-years. This information provides an estimate of the overall disease burden in this study base. However, we do not know how many cases would have arisen in the study base if all the women in this population had not been alcoholics. In epidemiology, the unexposed group stands in for the person-time experience of the exposed group had it not been exposed. Thus, we need to harvest information from both exposed and unexposed person-time. There are several ways through which an association, or lack thereof, is assessed. Consider a population of women exposed to a high saturated fat diet and a group exposed to low saturated fat diets that are followed for 5 years to see if they develop breast cancer. The absolute effect of the high-fat diet would be the difference in the cumulative incidence bet'ween the fwo groups, or the difference in the incidence rates. Since the experience of the low saturatedfatgroup should represent what would have h"ppened to the high saturated fat group if they had not eaten the high saturated fat, and if the n,rro groups are equivalent with respect to other breast cancer risk factors, the difference in risks or rates represents the excess risk or rate. These absolute-effect measures are called the risk difference and rate difference, respectively.
Although the absolute measures are easily interpreted, more common are effect measures that are taken as ratios and collectively known as the relatiue risA. This term includes the risk ratio, rate ratio, odds ratio, standardized mortaliry ratio, and standardized incidence ratio. The risk ratio is simply the cumulative incidence of disease among the exposed, divided by the cumulative incidence among the unexposed. The rate ratio is a ratio of the rates of disease among the exposed and unexposed. The odds ratio is the odds of disease among the exposed divided by the odds of disease among the unexposed. Lastly, the standardized mortality ratio or standardized incidence ratio is a ratio of the observed number of deaths or cases in a cohort, divided by the expected CONCEPTS IN CANCER EPIDEMIOLOGY AND ETIOLOGY I 1,44 number of deaths or cases in population, usually stratified gender. the general by age and A relative risk value of 1 implies that the exposure under study does not affect the incidence of the disease under consideration. Values below and above f. indicate a negative (inverse) and a positive association, respectively. For example, a relative risk of 0.5 implies that the disease occurs only half as frequently among exposed as among unexposed individuals; the studied factor appears to be protective. In contrast, if the relative risk is 1.5, then the occurrence (usually the incidence) is 50% higher among exposed than among unexposed individuals.
Studies based on follow-up of closed cohorts may be ana|yzed by using either cumulative incidence (risk) measures or by counting person-time and calculating incidence rate measures. Analyses based on cumulative incidence measures are only useful under certain conditions, such as no /oss to follow-up, no competing risks, and unchanged exposure status throughout follow-up. In addition, study subjects should be followed for the same period of time. \0fhether or not these conditions are met, it is always valid to conduct analyses based on person-time, using incidence rate measures.
Interaction
The term interaction has been used to describe different biological and statistical concepts. Indeed, even in the epidemiologic literature, statements about interaction are often ambiguous and inadequately specified. From a biological point of view, component causes within the same sufficient cause may be thought of as interacting (Fig. 6-1) . In other words, the exposures act synergistically to produce disease, since in the absence of one factor, disease will not occur by that mechanism. From an epidemiologic point of view, interaction is frequently characterized as effect-modification: That is, a factor A and factor B alone have a certain relationship with a disease, but together the factors have an effect different than that expected on the basis of the magnitude of their individual effects. The expectation of the joint effect of factors A and B can be assessed in either an additive or a multiplicative way.
'$7e can use the example in Table 6 -2 to illustrate how interaction is assessed. When a multiplicative scale is assumed, there is statistical interaction if the relative risk among those exposed to both factors A and B (that is, RRas) is different than the product of the two individual relative risks (that is, RRe x RRe). \fhen an additive scale is assumed, there is interaction if the RRes is different than (RRa + RRB -1).
In this exanrple, the expected relative risk for someone with both exposures is 5.0 (6.0--[4.0 + 3.0-1J) under the additiveeffect assumption (Table 6 -2A), whereas it is 12.0 (12.0:4.0 x 3.0) under the multiplicative-effect assumption (Table 6 -2F-l'. Hence, interaction between two exposures is present when the relative risk is significantly different from what is expected according to a specified scale. Thus, for those with both exposures, we would have interaction on the additive scale if the relative risk is significantly different from 6.0 (Table 5-2A) , and on the multiplicative scale if the relative risk is significantly different from Q.A Gable 6-2F-l.If the relative risk following exposure to both factors compared to having neither is greater than the sum (minus the reference risk of 1, which should not be counted twice) or product of the individual risks, we call this interaction super additiue or super multiplicatiue, respectively. If the relative risk is significantly lower, we refer to this as either subadditiue or submubiplicatiue. l 'Sfe can illustrate the concept of interaction using data from an epidemiological study of asbestos, smoking, and lung cancer risk. The source population for the data shown in Table 6 -2C is a cohort of insulation workers from the United States and Canada (Hammond et al, 19791 . The exposed person-time was the experience of over 12 000 male workers with at least 20 years of asbestos exposure. The comparison person-time came externally from the experience of more than 73 000 men of similar social class. Table G2 . Definitions of i exposed (+) or not exposed these factors comprise the -i,fo ndditive r."i., since i:j",r ilan,,, = 53.2 is substanr ;€fo rxpected relative risk "l"able 6-2. Definitions of interaction. Relative risks of developing a certain disease among subjects cxposed (+) or not exposed (-) to one or both factors denoted A and B. Subf ects exposed to neither of these factors comprise the reference category and their relative risk is by definition 1.0. Compared to men who had neither exposure, the relative risk of those who were smokers, but who were not exposed to asbestos occupationally was 10.9; the relative risk of those exposed to asbestos, but who were not smokers, was 5.2. For those exposed to both asbestos and smoking, the relative risk of lung cancer was 53.2 compared to those with neither factor. In this example, there appears to be interaction on the additive scale, since the RRr-oker and rrbestos:53.2 is substantially higher than lhe expected relative risk of 15.1 under the additive model (RRr-or". * RR"r6"..o, l-'1,0.9 + 5.2 -1).
CONC
'\J7e do not, however, observe interaction on the multiplicative scale, since the relative risk for both smoking and asbestos (53.2) does not represent a significant departure from what is expected under the multiplicative-effect assumption (55.7: RRr-ok.. x RR"r6"rasbestos -'1,0.9 x 5.2 ). There are not any clear-cut guidelines on whether to assess interaction in the additive or multiplicative sefting for the various disease outcomes examined in epidemiology, although both approaches are used (Brennan, t9991 .
Meta-analysis
Random variation per se in epidemiologic studies is not an insurmountable problem.
Larger studies and eventually quantitative summary analyses are increasingly used. Such systematic statistical evaluations of results of several independent investigations can effectively address genuine chancerelated concerns. Quantitative summary analyses have been termed meta-analyses andpooled analyses. There is no completely accepted distinction between the rwo terms, although meta-analysis is used more frequently when published results are combined. By contrast, in pooled analysis primary individual-level data from different studies may be made available to an investigator who undertakes the task of combining them. This facilitates the use of uniform exposure categories and statistical analyses across studies and may permit analyses that were not in the original publications. For instance, analyses of effect modification for which each initial study may have been too small to be informative.
Meta-analyses and pooled analyses have been widely and effectively used for randomized controlled trials and intervention studies, because in properly undertaken investigations of this nature confounding and bias are nonissues (Sacks et al, 1, 987) . For observational epidemiologic studies, however, the role of meta-analysis is not universally accepted (Shapiro, 1994; Feinstein, L995) . Some investigators are concerned that no statistical summarization can effectively address problems generated by residual confounding, unidentified bias, and the way investigators choose to present their results (legitimately, but occasionally selectively or arbitrarily). Nevertheless, metaanalyses have provided important, widely accepted data, even when derived from observational data.
CAUSAL INFERENCE IN EPIDEMIOLOGY General Principles
Regulatory agencies and policy makers may recommend standards, set limits, or authorize action even when the scientific evidence is weak. These decisions serve public health objectives by introducing a wide safety margin, but they should not be confused with the establishment of causation based on scientific considerations alone.
When results of an observational epidemiologic study designed to address a specific hypothesis are striking, the study is large, and there is no evidence of overt confounding or major biases, it is legitimate to attempt etiologic inferences. In contrast, interpretation becomes problematic when a weak association turns out to be statistically significant-for example, in a large but imperfect data set. Although that association could reflect.a weak-but genuine-<ausal association, it might also be the result of residual confounding, subtle unidentifiable bias, or chance, perhaps following a multiple testing process.
Repeated demonstration of an association of similar direction and magnitude in several studies, undertaken by different investigators in different population groups, increases confidence in a genuine causal basis but cannot conclusively establish this. Nor do meta-analyses establish causality. These techniques essentially address the issue of chance and provide no guarantee that a particular bias, unrecognized confounding, or selective reporting have not operated in the constituent studies. It is at this stage that both biologic and epidemiologic considerations should be taken into account in interpreting the results of empirical studies.
Criteria for inferring causation from epidemiologic investigations have been proposed, over the years, by several authors, including MacMahon et al (19601, the US Surgeon General (US Department of Health, 1964) , Sir Austin Bradford Hill (Hill, 1.965), the IARC (1987) , and others. In spite of differences in emphasis, a similar set of principles have been invoked by most authors. Sir Austin Bradford Hill (1965) advocated the nine widely used criteria listed in Table 6 -3,to distinguish causal from noncausal associations.
The Hill criteria, although sensible and useful, do not separately address the inherently different issues that are posed by the results of a single study, the results of several studies, and the likelihood of caucol sation in a certain indi perceived likelihood o befween a particular cific disease moves for a continuous spectrur accumulate. The evid declared as sufficienr threshold has been rea, requires reevalutation quent evidence (Cole, The IARC Classificati
The International Age Cancer (IARC) evalua agents to determine if in humans. In order t sion, the IARC has im1 of criteria for evaluar city of agenrs. After cr idence, the IARC work tgent to one of five cat Table 6 .'t,fui*l,,sv liation in a certain individual. In reality, the perceived likelihood of a causal association berween a particular exposure and a specific disease moves forward or backward in il continuous spectrum as research results accumulate. The evidence for causality is declared as sufficient when a oarticular rhreshold has been reached, but on occasion rcquires reevalutation in the light of subsequent evidence (Cole, 1997) .
The IARC Classification
The International Agency for Research on (lancer (IARC) evaluates the risk of specific agents to determine if they are carcinogenic in humans. In order to come to a conclusion, the IARC has implemented its own set of criteria for evaluating the carcinogenicity of agents. After considering all the evidence, the IARC working group assigns the agent to one of five categories, summarized Table 6 -4. Group 1 indicates that there is sufficient evidence to conclude that the agent is carcinogenic to humans. A label of group 2A means that there are insufficient human data, but there is strong evidence that the agent is carcinogenic in animal models. Agents for which there is limited evidence in humans and insufficient evidence in experimental animals are assigned to group 28. Group 3 is used when there is inadequate human and animal data to come to a conclusion. Group 4 indicates that the agent is most likely not a carcinogen in humans based on adequate evidence suggesting that it is not a carcinogen in both animal models and human studies. An association is more likely to be causal when it is observed in different population groups.
When an exposure is associated with a specific outcome only (for example, a cancer site or even better a particular histological type of this cancer), then it is more likely to be causal. There are exceptions, however, for example, smoking causing several forms of cancer.
A cause should not only precede the outcome (disease), but also the timing of the exposure should be compatible with the latency period (in noninfectious diseases) or the incubation period (in infectious diseases).
This criterion refers to the presence of an exposure-response relationship. If the frequency or intensity of the outcome increases when an exposure is more intense or lasts longer, then it is more likely that the association is causal.
An association is more likely to be causal when it is biologically plausible.
A cause and effect interpretation of an association should not conflict with what is known about the natural history and biology of the disease, or its distribution in time and place. If experimental evidence exists, then the association is more likely to be causal. Such evidence, however, is seldom available in human populations.
The existence of an analogy (for example, if a drug causes birth defects, then another drug could also have the same effect) could strengthen the belief rhat an association is causal.
Itwrce: Hill, 1955. 1,48
in this instance, a firm conclusion is all but impossible. In the approach introduced by Cole (19971, The indiuidual study (leuel I) Causality can never be inferred on the basis of a single epidemiologic study, but the likelihood that an observed association is causal is strengthened when several of the following criteria are met: (7)minimal confounding; (2) minimal bias; /3/ limited chance variation; (4) rclatively strong association; /5i monotonic exposure-disease association, otherwise referred to as exposure-response or dose-response association; (6) internal consistency, exemplified by similarity of exposure-response patterns among various subgroups of study subjects; (7) compatibility of the temporal sequence of exposure and outcome with the known or presumed latency of the disease; and, lastli, 8) Aiologic plausibiliry, that is, a causal link berween the exposure and the disease should be, at a minimum, biologically conceivable (it should not contradict physical theory or biological principles ).
The general case (seueral studies, leuel II) Establishment of the etiologic role of a particular exposure on the occurrence of a disease ideally requires strong epidemiologic evidence, an appropriate and reproducible animal model, and documentation atthe molecular or cellular level of the morphological or functional pathogenetic process. Sometimes, an intended or unintended change, or natural experiment, greatly facilitates etiologic inference: This happens when, for example, an occupational group is exposed to high levels of compounds rarely encountered in other seftings, a religious group avoids an exposure that is otherwise widespread, or a vaccine that creates herd immuniry against a particular virus turns out to reduce the incidence of a certain form of cancer. These conditions, however, are rarely collectively satisfied. Instead investigators have to be guided by the best available biomedical evidence in order to interpret correctly epidemiologic data from several studies. The following criteria need to be considered: (1) consistency, that is similarity (lack of heterogeneity) of results obtained by different investigators using different study designs in different populations; (2) overwhelming biomedical evidence for weak associations, whereas for strong associations reliance on powerful biomedical knowledge is less critical; (3) compatibiliry of exposure-response patterns across different studies exploring the exposure-disease association in different exposure ranges; (4) coherence, which requires results from analytic epidemiologic studies to be compatible with ecologic pat-CONC terns and time trends, su incidence of lung cancel ing the increasing use c by the population; (5) exists when one type c tently linked with one rather than several exP sociated with a certain of exposure being assc diseases; and (6) biolog exists when a similar shown to cause a simila species or a different fo humans. For example' shown to cause leukem species and at least one mia in humans.
None of these criteria absolutely necessary for sine qua non. But the evi strengthened when mos Disease in a specific Pe Causality can be con< between a particular e: and a particular disease trast, it is not possible link conclusively betwt a particular disease of for example, smoking i cancer. It is possible, h ductively that the spe ness was rnore likely th specified exposure.
For this conclusion following criteria must (1 The agent is carcinogenic to humans
The agent is probably carcinogenic to humans
The agent is possibly carcinogenic to humans
The agent is not classifiable in terms of its carcinogenicity
The agent is not carcinogenic to humans terns and time trends, such as the increasing incidence of lung cancer over time, following the increasing use of tobacco products by the population; (5) specificity, which exists when one fype of disease is consistently linked with one fype of exposure rather than several exposures all being associated with a certain disease, or one rype of exposure being associated with several diseases; and (5) biological analogy, which cxists when a similar exposure has been shown to cause a similar disease in another species or a different form of the disease in humans. For example, viruses have been shown to cause leukemia in several animal species and at least one rare form of leukemia in humans.
None of these criteria can be considered as absolutely necessary for causal inference-a sine qua non. But the evidence for causaliry is strengthened when most of them are met.
Disease in a specific person (leuel III) Causality can be conclusively established between a particular exposure as an entityand a particular disease as an entity. In contfast, it is not possible to establish such a link conclusively bet'ween an exposure and r particular disease of a given individualfor example, smoking in a patient with lung cancer. It is possible, however, to infer deductively that the specific individual's illness was more likely tban not caused by the cpecified exposure.
For this conclusion to be drawn, all the , following criteria must be met (Cole, 1, 997) 2 ', (1)The exposure under consideration, as an sntify, must be an established cause of the ,disease under consideration, as an entity {level W. Q) The relevant exposure of the particular individual must have properties : comparable (in terms of intensity, duration, I tssociated latency, etc) to those that have 'been shown to cause the disease under condderation. (3) The disease of the specified pcrson must be identical to, or within the i $tmptomatological spectrum of, the disease 'that, as an entity, has been etiologically linked to the exposure. ft)Thepatient must Bot have been exposed to another estabfished or likely cause of this disease. If the 149 patient has been exposed to both the factor under consideration (for example, smoking) and to another causal factor (for example, asbestos), individual attribution becomes a function of several relative risks, all versus the completely unexposed: (a) relative risk of those who only had the exposure under consideration, (b) relative risk of those who had only been exposed to the other causal factor(s), and, (c)relative risk of those who have had a combination of these exposures. (5) The relative risk should be reasonably elevated (e9,2 or more).
The last criterion stems from the fact that the relative risk comprises a baseline component equal to 1., which characterizes the unexposed, plus another component that applies only to the exposed. I7hen the relative risk is higher than 1 but less than 2 the individual who has been exposed and has developed the disease is more likely than not to have developed the disease for reasons not entirely due to the exposure. For instance, if the risk of a light-smoking 55-year-old man to suffer a first heart attack in the next five years is 67", and that of a sameage non-smoking man is 4"/" (relative risk 1..5), then only 33o/o of the smoker's risk (that is, 1/3 of the total 5"/o) cag be attributed to his smoking. I7hen the relative risk is higher than 2, apartrcular individual who has been exposed and has developed the disease under consideration is more likely than not to have developed the disease because of the exposure.
CONCLUSION
Manipulation of exposures in humans, many of which may be harmful, is frequently unfeasible, unethical, or both. Therefore, epidemiologists have to base their inferences on experiments that humans subject themselves to intentionally, naturally, or even unconsciously. The study of risk for lung cancer among smokers compared with nonsmokers is one classic example of a natural experiment.
Because human life is characterized by myriad complex, often interrelated, behaviors and exposures-ranging from genetic :tiologic role of a parre occurrence of a disstrong epidemiologic 'iate and reproducible :umentation at the mo-,l of the morphological enetic process. Someunintended change, or treatly facilitates etiorappens when, for exal group is exposed to nds rarely encountered igious group avoids an :wise widespread, or a :rd immunity against a out to reduce the inrrm of cancer. owever, are rarely col-:ead investigators have st available biomedical nterpret correctly epin several studies. The d to be considered: (L) imilarity (lack of hetobtained by different ifferent study designs >ns; (2) overwhelming for weak associations, ;sociations reliance on knowledge is less crit-' of exposure-response rent studies exploring rssociation in different coherence, which rernalytic epidemiologic ible with ecologic pattraits and features of the intrauterine environment to growth rate; physical activity; sexual practices; use of tobacco, alcohol, and pharmaceutical compounds; dietary intake; exposure to infections, environmental pollutants, and occupational hazards; and so on-epidemiologic investigation is difficult and challenging. Given this complexity, it is not surprising that from time to time epidemiologic studies generate results that appear confusing, biologically absurd, or contradictory. However, it is reassuring that a wealth of new knowledge has been generated by epidemiologic studies over the last few decades. This knowledge now lays the scientific ground for primary prevention of many major cancers and other chronic diseases among humans globally.
A detailed study of epidemiologic methodology in any textbook (Hennekens and Buring, 1987; Miettinen, 1985; Walker, 7991; MacMahon and Trichopoulos' 1995; Rothman and Geenland, 1,998; Rothman, 2002) can be fascinating and indeed necessary for those who want to pursue their own research. However, for the reader of this textbook, the general concepts introduced in this chapter should provide a sufficient basis. We have tried to convey that the sometimes esoteric theory of modern epidemiology can be condensed to a few central issues-namely (1) how to quantify and understand the impact of chance , (2)how to best harvest information on exposures and outcomes from a source population by using a cohort design, a case-control design, or variants thereof, (3) how to achieve valid results by minimizing the impact of confounding and bias, and, (4) how to address the central issue of causality in a structured way.
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BACKGROUND
Closed cohort A closed cohort comprises a set of individuals who are followed for a defined period of time. After becoming a member of the cohort, an individualremains in the cohort until the end of the study. or development of the outcome.
Competing risks The risk of death from a certain disease competes with the risk of death from another disease by affecting time at risk. Competing risks generally bias risk ratios, but not rate ratios, since person-time allows for different follow-up time.
Component cause An exposure that acts in concert with other factors (component causes) to produce disease. None of these factors are sufficient in themselves to cause disease.
Confidence interaal A statistical measure that provides range of possible values that include the true measure of association with a particular degree of certainty. For example, a 95% confidence interval provides a range of values that will include the true value 95% of the time.
Confounding A systematic error generated when another factor, that causes the disease under study or is otherwise related with it, is also related to the exposure under investigation, without being in the pathway that links exposure under investigation with the disease under study.
Ecologic study The study of exposure and the disease at the population level, rather than at the individual level.
Epidemiology The nonexperimental investigation of determinants of human disease.
Experimental study See randomized controlled trial Infonnation bias A random, or nonrandom, misclassification of information on either the exposure, outcome, or confounding variables that leads to a biased estimation of the true effect.
Cause A factor is a cause of a certain disease Loss to follow-up The inability to follow when alterations in the frequency or intenbeyond a certain point in time and thus sity of this factor-without concomitant ascertain the ultimate fate of individuals in alterations in other factors-are followed a cohort study.
by changes in the frequency of occurrence of Necessary cause A factor or exposure that the disease, after the passage of a certain is essential in the etiology of the disease and time period (latency, or induction period).
without which the disease cannot occur. >sed cohort comprises
